Walmart to Replace Astrazeneca on Nasdaq-100 on Jan. 20

Walmart to Replace Astrazeneca on Nasdaq-100 on Jan. 20
A Walmart worker in a holiday costume gathers shopping carts in the parking area of a Walmart Supercenter store in Monroe, New York, U.S., December 9, 2025. Mike Segar/Reuters
|Updated:
0:00

Walmart will replace British drugmaker AstraZeneca in the Nasdaq-100 Index on January 20, the exchange operator said on Friday.

The retail giant said in November it would shift its longtime listing on the New York Stock Exchange to its main rival.